Our finding that Ivermectin potentiates P2X4/P2X7 purinergic signaling in cancer cells correlates to the ATP rich tumor microenvironment, thus providing a mechanistic explanation for this phenomenon. This evidence concerns the gene P2RX7 and cancer.